Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and a glutaminase inhibitor
WO2021034631A1
Methods and pharmaceutical compositions containing 4,6-bis(benzylthio)hexanoic acid for treating cancer
WO2021011334A1
Deuterated derivatives of 6,8-bis(benzylsulfanyl)octanoic acid
WO2020191144A1
Therapeutic methods and compositions for treating lymphoma using 6,8-bis-benzylthio-octanoic acid
TW202038930A
Oral therapy using 6,8-bis-benzylthio-octanoic acid
TW202038932A
Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor
TW202038931A
Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor
WO2020112966A1
Therapeutic methods and compositions for treating acute myeloid leukemia using devimistat
CA3102865A1
Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis(benzylsulfanyl)octanoic acid
TW202019403A
Use of a first therapeutic agent comprising 6,8-bis(benzylsulfanyl)octanoic acid or a pharmaceutically acceptable salt thereof in the preparation of amedicament for treating pancreaticcancer
KR20210023813A
Treatment methods and compositions for treating prostate cancer using 6,8-bis-benzylthio-octanoic acid
